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Abstract
Background: Apaf1 (apoptotic protease activating factor 1) is the central component of the apoptosome, a multiprotein
complex that activates procaspase-9 after cytochrome c release from the mitochondria in the intrinsic pathway of apoptosis.
Other cellular roles, including a pro-survival role, have also been described for Apaf1, while the relative contribution of each
function to cell death, but also to cell homeostatic conditions, remain to be clarified.
Methodology and Principal Findings: Here we examined the response to apoptosis induction of available embryonic
fibroblasts from Apaf1 knockout mice (MEFS KO Apaf1). In the absence of Apaf1, cells showed mitochondria with an altered
morphology that affects cytochrome c release and basal metabolic status.
Conclusions: We analysed mitochondrial features and cell death response to etoposide and ABT-737 in two different Apaf1-
deficient MEFS, which differ in the immortalisation protocol. Unexpectedly, MEFS KO Apaf1 immortalised with the SV40
antigen (SV40IM-MEFS Apaf1) and those which spontaneously immortalised (SIM-MEFS Apaf1) respond differently to
apoptotic stimuli, but both presented relevant differences at the mitochondria when compared to MEFS WT, indicating a
role for Apaf1 at the mitochondria.
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Introduction
Apoptosis is an essential process of programmed cell death for
normal development, cell homeostasis, and also as a defence
mechanism to eliminate harmful cells, such as tumour cells or cells
infected by viruses. It is characterised by specific morphological
changes, such as shrinkage of cell and chromatin condensation.
Apoptosis can be triggered by extrinsic (death receptor-mediated
[1]) or intrinsic (mitochondrial) pathways. The intrinsic pathway
can be initiated by many stresses [2], and both pathways can
provoke mitochondrial outer membrane permeabilisation
(MOMP) mediated by proteins of the Bcl-2 family (Bcl-2s).
Cytochrome c (Cyt c) is then released into the cytosol and induces
the formation of the apoptosome complex. The apoptosome is a
holoenzyme complex formed by Cyt c-activated Apaf1, dATP and
procaspase-9 [3,4]. Apoptosome-bound procaspase-9 is activated,
and subsequently proteolyses and activates downstream effector
caspases, leading to the progression of cell death. Apaf1 is a
135 kDa protein that is known for its apoptotic role. However,
recent studies have suggested additional non-apoptotic functions
for Apaf1, including a pro-survival role [5–10]. How these, in
principle, opposite functions of the protein operate in cells remains
a controversial matter, and there are still important questions to
answer about the Apaf1 biological function, not only when cells
die, but also under homeostatic conditions.
Although the cells deriving from Apaf1 knockout (KO) animals
are expected to be resistant to the majority of apoptotic insults,
different laboratories have presented evidence that some, but not
all, immortalised Apaf1-deficient cell types can switch between
apoptotic and necrotic cell death [11–14]. These differences might
be related to an influence of the immortalisation process on the
availability of cell death signalling components [15,16] or to a
more complex role of Apaf1 in the cell than expected. In addition,
the relationship between the extent of Cyt c release from the
mitochondria and the completeness of downstream apoptotic
signalling is still controversial. Studies at the single cell level have
provided clear evidence for a single-step release mechanism of Cyt
c and of other mitochondrial proteins, such as Smac/DIABLO,
even in Apaf1-deficient cells [17,18]. Moreover in cells of different
origins lacking Apaf1, it has been reported that Cyt c-release is
either inhibited [12] or, in contrast, it increases [9]. Furthermore,
the pharmacological inhibition of Apaf1 has been reported to
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induce a reduction in the total amount of Cyt c released from a cell
population [7].
Here we report a profound characterisation of available
embryonic fibroblasts from Apaf1 KO mouse (MEFS KO Apaf1).
We found that distinct MEFS KO Apaf1 cells behave differently in
response to apoptotic insults. We analysed the apoptotic response
to such insults, as well as the mitochondrial and metabolic status in
MEFS KO Apaf1, which were spontaneously immortalised (SIM)
or immortalised by the transfection of the SV40 antigen
(SV40IM). In the absence of Apaf1, cells present mitochondria
with an altered morphology which affects Cyt c release and basal
metabolic status.
Materials and Methods
Cell culture, treatments and chemicals
All the cell lines were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% foetal bovine serum
(FBS). Cultures were maintained at 37uC in a 5% CO2
atmosphere. Cell media and FBS were purchased from GIBCO
BRL Life Technologies. When indicated, cells were treated with
5 mM of etoposide (E), acquired from Sigma Aldrich. When
required, 100 mM necrostatin (Nec; Enzo Life Sciences), 10 mM
SVT016426 (SVT) or 5 mM Z-Val-Ala-Asp(OMe)-fluoromethylk-
etone (zVAD; Tocris) were administered 1 h prior to treatment
addition, and cells were maintained in culture for 24 h. MEFS cell
lines were previously established in the referenced publications
[4,9]. For the MEFS cells established by spontaneous immortalisa-
tion (SIM), two clones of each cell line (WT and KO Apaf1) were
tested. No intrinsic variability was observed between them.
LipofectamineTM 2000 (Invitrogen) was used according to the
manufacturer’s instructions to transfect HeLa cells with a control
random siRNA (Rsi) and Apaf1 siRNA (Asi), obtained from Cell
Signaling.
Caspase activity determination
Cell extracts were prepared from 2.06105 cells seeded in 6-well
plates. After 24 h, cells were treated as indicated above, and were
scraped and washed with PBS. Pellets were lysed in extraction
buffer (50 mM PIPES, 50 mM KCl, 5 mM EDTA, 2 mMMgCl2,
2 mM DTT, supplemented with protease inhibitors). Having
frozen and thawed three times, cell lysates were centrifuged at
14,000 rpm for 5 min and supernatants were collected. Quanti-
fication of the total protein concentration was performed by the
BCA protein assay (Thermo Scientific). Total protein (50 mg) was
mixed with 200 mL of caspase assay buffer (PBS, 10% glycerol,
0.1 mM EDTA, 2 mM DTT) containing 20 mM Ac-DEVD-afc
(Enzo Life Sciences) of the caspase-3 substrate. Caspase activity
was continuously monitored following the release of fluorescent afc
at 37uC with a Wallac 1420 Workstation (lexc = 400 nm;
lem= 508 nm). Caspase-3-like activity was expressed as the
increase of relative fluorescence units per min (A.U.).
Trypan blue exclusion assay
Cells were seeded in 6-well plates at a cellular density of
2.06105 cells/well. After 24 h, cells were treated as described
before to be then detached, and 0.05% trypan blue dye was added
in solution. Live cells possess intact cell membranes that exclude
the dye, whereas dead cells do not. Unstained (viable) and stained
(non-viable) cells were counted separately in a haemacytometer
and the total number of viable cells in the population was
calculated.
Nuclear staining
The cells cultured on coverslips were stained with 300 nM 49-6-
diamidino-2-phenylindole (DAPI) solution. The morphology of
cells’ nuclei was observed under a fluorescence microscope (Leica
Vertical DM6000) at the 350 nm excitation wavelength. Nuclei
are considered to have the normal phenotype when they glow
brightly and homogenously. Apoptotic nuclei can be identified by
either a condensed chromatin gathering at the periphery of the
nuclear membrane or a total fragmented morphology of nuclear
bodies.
Immunoblotting
Whole cell extracts were obtained by lysing cells in a buffer
containing 25 mM Tris-HCl pH7.4, 1 mM EDTA, 1 mM EGTA,
1% SDS, plus protease and phosphatase inhibitors. Protein
concentration was determined by the BCA protein assay. Cell
lysates were resolved by SDS-PAGE, transferred to nitrocellulose
membranes, blocked with 5% non-fat milk, washed with 0.1%
Tween/PBS and incubated overnight with a specific primary
antibody. Membranes were washed and probed with the
appropriate secondary antibody conjugated with horseradish
peroxidase for enhanced chemiluminescence detection (Amersham
Pharmacia Biotech). The antibody against Apaf1(#611365) was
acquired from BD Biosciences, Bcl-XL (#2764) and Bcl-2(#2870)
came from Cell Signaling, and a-tubulin antibody (#T8203) was
purchased from Sigma-Aldrich.
DIOC staining
Cells were incubated with 50 nM 3,39-Diethyloxacarbocyanine
iodide (DiOC2(3)) at 37uC, 5% CO2, for 15 minutes in 500 mL of
PBS. Then, samples were analysed in a Cytomics FC 500
(Beckman Coulter) flow cytometer with 488 nm excitation using
the appropriate emission filters for Alexa Fluor H 488 dye.
Cytochrome c release assay
MEFS cells were grown in 6-well plates under the same
conditions described above. After 24 h of etoposide treatment,
mitochondrial Cyt c was followed using the InnocyteTM Flow
Cytometric Cytochrome c Release kit (Calbiochem). Cells were
analysed in a Cytomics FC 500 (Beckman Coulter) flow cytometer.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde, permeabilised with
0.1% Triton X-100, and blocked in 2% gelatin in PBS. Then they
were labelled with a primary antibody against Cyt c (SC13561;
Santa Cruz), followed by anti-mouse IgG conjugated with FITC
(Jackson ImmunoResearch). Images were obtained under a Leica
DM 6000 microscope (Leica DC500 camera) with a 206
objective. Two hundred cells were counted and classified
according to the localisation of Cyt c in the mitochondria (tubular
morphology) or cytosol (diffuse pattern).
Transmission electron microscopy
MEFS cells were seeded at 36104 cells per chamber on Lab-
Tek chamber slides of 4 wells (Nalge Nunc International). Then,
cells were fixed for 1 h in 3.5% glutaraldehyde at 37uC and
postfixed for 1 h in 2% OsO4 at room temperature. Cellular
staining was performed at 4uC for 2 h in 2% uranyl acetate in the
dark. Finally, cells were rinsed in sodium phosphate buffer (0.1 M,
pH 7.2), dehydrated in ethanol and infiltrated overnight in
Araldite (Durcupan, Fluka, Buchs SG, Switzerland). Following
polymerisation, embedded cultures were detached from the
chamber slide and glued to Araldite blocks. Serial semi-thin
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(1.5 mm) sections were cut with an Ultracut UC-6 (Leica, Leica,
Heidelberg, Germany), mounted onto slides and stained with 1%
toluidine blue. The selected semi-thin sections were glued (Super
Glue, Loctite) to araldite blocks and detached from the glass slide
by repeated freezing (in liquid nitrogen) and thawing. Ultrathin
(0.07 mm) sections were prepared with the Ultracut UC-6 and
stained with lead citrate. Finally, photomicrographs were obtained
under a transmission electron microscope (FEI Tecnai Spirit G2)
using a digital camera (Morada, Soft Imaging System, Olympus).
Then, mitochondrial width was quantified by using the Image J
Java-based image processing software (NIH).
ATP, lactate and pyruvate measurements
HeLa cells were seeded at a density of 56104 cells/mL. An
ATP measurement was taken in duplicate by employing the
Luminescence ATP Detection Assay System (Perkin Elmer)
according to the manufacturer’s instructions. The KO MEFs
results were normalised to their respective WT controls. Lactate
was measured with the Lactate Assay Kit II (BioVision) following
the manufacturer’s instructions. Pyruvate was measured using the
Pyruvate Assay Kit (BioVision) according to the manufacturer’s
instructions. The KO MEFs results were normalised to their
respective WT controls.
Results and Discussion
The embryonic fibroblast cell lines from wild-type (MEFS WT)
and from Apaf1 KO mouse (MEFS KO Apaf1) [4] were
previously established by spontaneous immortalisation (SIM) or
by infection with SV40 antigen T (SV40IM) [9]. The cell lines
were analysed to study the relevance of Apaf1 in the homeostasis
of the cell and their behaviour upon apoptotic stimuli. As an
apoptotic insult, we used etoposide, a DNA damage-inducing drug
that is well-characterised as an intrinsic apoptosis inducer [19].
SV40IM-MEFS KO Apaf1 cells were more sensitive to etoposide
than SV40IM-MEFS WT as manifested by lower counts of cell
survival determined by trypan blue exclusion (Fig. 1A). In contrast,
and as initially expected [4], SIM-MEFS KO Apaf1 cells were
resistant to etoposide (Fig. 1A), while SIM-MEFS WT cells showed
a similar percentage of death to SV40IM-MEFS WT cells. SIM-
MEFS WT and SV40IM-MEFS WT death concurred with
caspase activation, while etoposide-induced death in SV40IM-
MEFS KO Apaf1 proceeded without caspase activation (Fig. 1B).
In etoposide-induced SV40IM-MEFS WT, caspase-3 activity
diminished in the presence of the irreversible caspase inhibitor
Z-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD) and in the
presence of the Apaf1 inhibitor SVT016426 (SVT) (not shown),
while cell viability increased only in the presence of SVT016426
(Fig. 1C). Neither RIPK1 inhibitor necrostatin (Nec) nor zVAD
had any effect on cell viability in these cells. In contrast in
SV40IM-MEFS KO Apaf1 cells, neither zVAD nor SVT016426
influenced cell death, while Nec increased cell survival, suggesting
that these cells can engage alternative death pathways as
necroptosis in the absence of Apaf1. In fact nuclear morphology
studies by DAPI staining showed that when cells were treated with
etoposide, SV40IM-MEFS KO Apaf1 cells did not present
apoptotic nuclear bodies as SV40IM-MEFS WT cells did (white
arrows; Fig. 1D). Instead dead KO Apaf-1 cells showed smaller
and brighter nuclei (Fig. 1D). In order to clarify which of the two
cell line systems was physiologically more relevant, Apaf1 was
depleted transiently by siRNA in HeLa cells (due to the difficulty
of transfecting MEFS cells) and was treated with etoposide. When
the HeLa cells transfected with a control random siRNA were
treated with etoposide, caspase-3-like activity (Figure 1E) was
observed and cell death came close to 60% (figure 1F). However in
the Apaf1 siRNA-based knockdown cells, caspase-3-like activity
diminished with a slight decrease in cell death of the cell
population (Figure 1E and F), which might be explained by the
fact that, in the absence of Apaf1, etoposide induced caspase-
independent cell death in these cells, as described previously
elsewhere ([11,20] These results indicate that the SV40 immor-
talised and the siRNA Apaf-1 transient depleted cells behave
similarly. Thus the SV40 immortalisation procedure better reflects
the punctual elimination of Apaf-1 from the cell than the SIM
immortalisation procedure, which probably reproduces the
adaptation and selection process produced by the permanent
absence of Apaf-1 in the cell. From the pharmacological point of
view, both models could probably be relevant depending on the
chronic or acute nature of the treatment with Apaf-1 inhibitors
required for disease resolution.
Next we evaluated the mitochondrial membrane potential
(DYm). It is well-accepted that DNA-damaging agents, such as
etoposide, induce signalling processes that convey into the
mitochondria by inducing Cyt c release and a subsequent decrease
in DYm [17]. With etoposide-treated SV40IM-MEFS KO Apaf1,
the population of cells with low DYm increased when compared to
the SV40IM-MEFS WT cells (Fig. 2A). As expected from the
previous cell death susceptibility results (Fig. 1A), the resistant
SIM-MEFS KO Apaf1 cells showed less cells with low DYm than
SIM-MEFS WT (Fig. 2A). Then we examined the release of Cyt c
from the mitochondria after the etoposide treatment in both cell
line types by flow cytometry. SV40IM-MEFS KO Apaf1 released
more Cyt c to the cytosol than the equivalent SV40IM-MEFS
WT. However, SIM-MEFS KO Apaf1 released less Cyt c than the
control SIM-MEFS WT (Fig. 2B). These results correlate well with
previous death sensitivity findings (Fig. 1A, B and C) and
mitochondrial membrane potential (Fig. 2A). The immunocyto-
chemistry experiments in the SV40IM-MEFS cell lines confirmed
that Cyt c was located mainly in the mitochondria in the absence
of a cell death inducer (Fig. 2C). Nevertheless, etoposide induced
Cyt c release from the mitochondria to the cytosol in about 30% of
SV40IM-MEFS WT cells and in around 70% of SV40IM-MEFS
KO Apaf1 (Fig. 2C). All these results suggest that upon etoposide
induction, Cyt c release is enhanced in the SV40IM-MEFS KO
Apaf1 cells, which is in agreement with early kinetic observations
[9]. Yet due to the absence of Apaf1, the death signalling wave
probably proceeds through a necroptosis-like pathway. Thus, the
immortalisation process may affect the genetic background and
might be responsible for the differences between both MEFS KO
Apaf1 cellular models. ABT-737 treatment induced activation of
caspase-3 and death in SV40IM-MEFS WT. However in
SV40IM-MEFS KO Apaf-1 and SIM-MEFS, both parameters
remain unaffected (Fig. S1). These results suggest that ABT737-
triggering signalling is not fully perceived by the cell, while DNA
damaging agents may activate alternative cell death pathways
when the intrinsic pathway of apoptosis is blocked. These results
indicate that the differences between both KO cell lines probably
lie at the mitochondrial level and not necessarily in the nuclear
signalling events responsible for apoptosis induction.
Next we performed a series of analyses for the characterisation
of both SV40IM- and SIM-MEFS KO Apaf1. The proteins of the
Bcl-2 family have been described to participate in MOMP
regulation [21]. It has been reported that SV40IM-MEFS KO
Apaf1 exhibits a lower expression of anti-apoptotic proteins Bcl-2
and Bcl-XL [9], which might be related to the differences observed
in Cyt c release. We found that not only SV40IM-MEFS KO
Apaf1, but also SIM-MEFS KO Apaf1 show low levels of Bcl-2
and Bcl-XL (Fig. 3A). In addition, SV40IM- and SIM-MEFS KO
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Apaf1 present a fragmented mitochondrial network (Fig. 3B),
which correlates well with recently reported data and suggests that
in SV40IM-MEFS KO Apaf1, the fission protein Drp1 localises in
the mitochondria to a greater extent than in MEFS WT, thus
favouring a fragmented mitochondrial network [9]. Next, we
examined the ultra-structure of mitochondria by transmission
Figure 1. Caspase-independent cell death in SV40IM Apaf1 KO cells. (A) Cell survival was measured by the trypan blue exclusion assay in
SV40IM and SIM MEFS, WT and Apaf1-depleted cells in the presence of etoposide (5 mM) for 24 h. (B) Caspase-3-like activity was measured under the
same etoposide treatment conditions (+; 5 mM) described above. In all cases, bars represent the mean of three experiments6 s.d. (C) Cell survival was
measured in the SV40IM cell lines treated with etoposide (5 mM) in the presence or the absence of z-VAD (5 mM), necrostatin (Nec; 100 mM) or
SVT016426 (10 mM). (mean6 s.d, n = 3, *p#0.05). (D) DAPI staining to analyse the apoptotic features between WT and Apaf1 KO cells in the presence
of etoposide (5 mM). In all, 500 nuclei were counted and classified according to apoptotic nuclear bodies (white arrows). Quantification is shown in
the right panel. (E) Cell survival was measured by the trypan blue exclusion assay in the HeLa cells transfected with random siRNA (Rsi) or Apaf1 siRNA
(Asi) for 24 h and treated with etoposide (+; 5 mM) for another 24-hour period. (F) Caspase-3-like activity was measured under the same conditions
described above. Bars represent the mean of three experiments 6 s.d. The immunoblotting of the Apaf1 silencer is shown in the right panel.
doi:10.1371/journal.pone.0084666.g001
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electron microscopy (TEM). The mitochondria in the control
MEFS WT cells were rounded with well visible cristae (Fig. 3C -
black arrows in the WT-labelled panels). However, the mitochon-
dria in the Apaf1-deficient cells (in both SV40IM- and SIM-MEFS
KO Apaf1) were rather elongated and thinner (Fig. 3C - black
arrows in the KO-labelled panels). Mitochondrial morphology
changes have been linked to alterations of the cell’s metabolic
status [22]. These observations have been confirmed by the
quantification of mitochondrial dimensions. Since samples were
cut in the preparation process (see Methods), we assessed only
mitochondrial width. In SV40IM-MEFS KO Apaf1, mitochon-
drial width decreased by an average 33% when compared to
SV40IM-MEFS WT (Fig. 3C, right panel), while a 52% reduction
in width was obtained in SIM-MEFS KO Apaf1 when compared
to SIM-MEFS WT (Fig. 3C, right panel). It was also interesting to
notice that the mitochondria in the MEFS WT control cells were
mostly in the ‘orthodox’ state [23], whereas they were in a
‘condensed’ state, with greater electron density in the matrix, in
MEFS KO Apaf1. These two different mitochondria ‘states’ have
been previously characterised. In fact, ‘mitochondria states’ are
related to mitochondrial status, and mitochondria populate one
‘state’ or the other depending on ADP availability. Mitochondria
display ‘condensed’ conformation when ADP is in excess, but they
revert to the ‘orthodox’ state when ADP is limiting [24,25]. Then
the TEM analysis suggests that in both SV40IM-MEFS KO Apaf1
and SIM-MEFS KO Apaf1, mitochondria are more active than in
the control MEFS WT cells. In fact, we analysed the levels of
intracellular ATP in SV40IM- and in SIM-MEFS KO Apaf1 to
find that the two cell lines showed a significantly higher ATP
content when compared to SV40IM- and SIM-MEFS WT
(Fig. 4A). In SV40IM MEFS KO Apaf1, ATP almost doubled
the content of the control cells (from 100.060.0 in SV40IM-
MEFS WT to 196.6628.42), while a 60% increase was observed
in SIM-MEFS KO Apaf1 (from 100.060.0 in SIM MEFS WT to
161.863.740).
ATP production can vary to match energy demands [26]. ATP
is produced from carbon fuels through glycolysis in the cytosol and
via oxidative phosphorylation (OxPhos) in mitochondria. Glycol-
ysis produces pyruvate for OxPhos under non-stressful conditions
to generate 2 moles of ATP from 1 mole of glucose. However
under stress due to a sudden drop in intracellular ATP, cells
accelerate glycolysis through which the ATP generation rate
becomes almost 100 times faster than that of OxPhos, be it with
poor ATP production efficiency. Consequently, it leads to
Figure 2. SV40IM Apaf1 KO cells showed faster Cyt c release. (A) Membrane potential study through DIOC2(3) staining in all the cell types
upon etoposide treatment (+; 5 mM). (B) Percentage of cells with mitochondrial Cyt c measured by the cytometry analysis after incubation with
etoposide (+; 5 mM) (mean 6 s.d., n = 3). (C) Immunofluorescence against Cyt c in SV40IM WT and Apaf1 KO MEFS in the absence (Control) or
presence of etoposide (E, 5 mM). In all, 200 cells were counted and classified according to mitochondrial or cytosolic Cyt c staining (white arrows).
Quantification is shown on the right as the percentage of cells with cytosolic Cyt c staining (mean 6 s.d., n = 3).
doi:10.1371/journal.pone.0084666.g002
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increased lactate production from pyruvate [27]. Then if the
structural differences found in the mitochondria in MEFS KO
Apaf1 can affect OxPhos, we should find increased lactate/
pyruvate (L/P) ratios in these cells. In fact, it has been formerly
reported that upon apoptotic treatment, the cell metabolism in the
apoptosome-deficient cells is maintained by glycolysis [28]. We
Figure 3. Mitochondrial network in Apaf1-deficient cells is affected. (A) Bcl-2 and Bcl-XL protein levels in the SV40IM and SIM cell lines by
immunoblotting. a-tubulin was also assayed as a loading control. Densitometric analyses were performed using the Image J software, normalised for
a-tubulin and reported as arbitrary units (a.u). Values are means 6 s.d. of three independent immunoblots. (B) The mitochondrial network in the
untreated SV40IM and SIM MEF cell lines was visualised using an anti-Cyt c antibody. (C) Transmission electron photomicrographs of the
mitochondria in MEFs. Ultrathin (0.07 mm) sections of the MEF cell lines were prepared as described in sMaterials and Method. Black arrows indicate
the representative mitochondria of each sample. Scale bars indicate 1 mm. The Image J Java-based image processing software was used to quantify
the width of approximately 70 different mitochondria from each cell type using the images obtained by TEM. Two-tailed Student’s t-tests were
performed (***p#0.001). SV40IM-MEFS WT Apaf1 is of 0.293960.01501 mm and SV40IM-MEFS KO Apaf1 is of 0.198060.009215 mm. SIM-MEFS WT
Apaf1 is of 0.353960.01625 mm and SIM-MEFS KO Apaf1 is of 0.169760.02228 mm.
doi:10.1371/journal.pone.0084666.g003
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found that this was indeed the case in SV40IM-MEFS KO Apaf1
(Fig. 4B), suggesting that the main ATP source for these cells
should be based on an increased glycolytic rate [29]. Conversely in
the SIM-MEFS KO Apaf1 cells, we found that the L/P ratio was
slightly lower as compared to the SIM-MEFS WT cells, suggesting
the major relevance of OxPhos in ATP production in these cells.
Next we reasoned as follows: if SIM-MEFS KO Apaf1 cells
depend on OxPhos for ATP production, while SV40IM-MEFS
KO Apaf1 cells rely on the glycolytic rate, then SIM-MEFS KO
Apaf1 cells should be more sensitive to oligomycin (an inhibitor of
mitochondrial ATP synthase) than the SV40IM-MEFS KO Apaf1
cells. Therefore, both KO Apaf1 cells were treated with
oligomycin, while mitochondrial activity was evaluated by MTT.
Dependence on ATP synthase can be clearly seen when
comparing the results with the respective MEFS WT cells. The
SV40-MEFS KO Apaf1 cells were more resistant to oligomycin
than the control SV40-MEFS WT (Fig. 4C). However, SIM-
MEFS KO Apaf1 cells were slightly more sensitive to the drug
than the SIM-MEFS WT control cells (Fig. 4C).
In conclusion, we analysed mitochondrial features and cell
death response to etoposide in two different Apaf1-deficient MEFS
that differ in the immortalisation protocol. Unexpectedly, both,
MEFS KO Apaf1 immortalised with the SV40 antigen (SV40IM-
MEFS Apaf1) and those that spontaneously immortalised (SIM-
MEFS Apaf1), presented relevant structural differences at the
mitochondria when compared to MEFS WT, indicating a role for
Apaf1 at the mitochondria. In fact when Apaf1 was absent, the
mitochondria appeared more fragmented, elongated and thinner
when compared to the MEFS WT mitochondria from animals
with the same genetic background (SV40IM-MEFS WT and SIM-
Figure 4. Metabolic status in Apaf1-deficient cells. (A) Absolute level of intracellular ATP in Apaf1-deficient MEFs is greater than in WT cells.
ATP content was measured using the commercially available Luminescence ATP Detection Assay System (Perkin Elmer) following the manufacturer’s
instructions. The results obtained from each Apaf1-deficient cell line were normalised to their respective WT controls and were submitted to the two-
tailed Student’s t-test (*p#0.05; ***p#0.001).). The ATP in SV40IM-MEFS WT Apaf1 is of 100.060.0 and of 196.6628.42 in SV40IM-MEFS KO Apaf1. The
ATP in SIM-MEFS WT Apaf1 is of 100.060.0 and of 161.863.740 in SIM-MEFS KO Apaf1. (B) Lack of Apaf1 in MEFs affects its lactate to pyruvate (L/P)
ratio. Lactate and pyruvate contents were measured using the commercially available Lactate Assay Kit II (BioVision) and the Pyruvate Assay Kit
(BioVision) following the manufacturer’s instructions. The results obtained from each Apaf1-deficient cell line were normalised to their respective WT
controls and submitted to the two-tailed Student’s t-test (*p#0.05; ***p#0.001). The L/P ratio in SV40IM-MEFS KO Apaf1 represents 188.9% of
SV40IM-MEFS WT Apaf1 and SIM-MEFS KO Apaf1 represent 76.39% of SIM-MEFS WT Apaf1. (C) Apaf1-deficient MEFs were able to obtain ATP from
both OxPhos and glycolysis. Cells from each cell line were treated with 0, 5 or 50 mM oligomycin for 24 h to block mitochondrial ATP synthase and
were submitted to the MTT cell proliferation assay. The obtained results were normalised in relation to the 0 mM oligomycin control for each cell line
and were submitted to the two-tailed Student’s t- test (****p#0.0001). The cell viability of SV40IM-MEFS WT as compared with SV40IM-MEFS KO
Apaf1 changed from 81.3261.06% to 72.2363.08% at 5 mM oligomycin and from 17.7260.62% to 5.9660.2% at 50 mM oligomycin. The cell viability
of SIM-MEFS WT Apaf1 as compared with SIM-MEFS KO Apaf1 changed from 84.1361.89% to 72.2362.52% at 5 mM oligomycin and from
43.0162.67% to 17.8966.86% at 50 mM oligomycin.
doi:10.1371/journal.pone.0084666.g004
Apaf1 Influences Mitochondria Morphology
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e84666
MEFS WT). These irregular mitochondria were predominantly
found in a ‘condensed’ state and contained higher ATP levels than
the counterpart mitochondria in MEFS WT. However, the origin
of this ATP accumulation in the mitochondria was not clearly
revealed, provided that the SV40IM-MEFS KO Apaf1 cells
showed a more marked dependence on ATP production with high
glycolytic rates, while SIM-MEFS KO Apaf1 were more
dependent on OxPhos. Furthermore, etoposide-treated SV40IM-
MEFS KO Apaf1 released more Cyt c and showed more cells with
low DYm than the counterpart cells from the WT animals. These
cells died by caspase-independent processes, which were partially
inhibited by Nec. In contrast, the SIM-MEFS KO Apaf1 cells
were resistant to etoposide treatments as they maintained DYm
and showed minimal Cyt c release.
Hence the genetic background and immortalisation protocol
might influence cells’ response to death signals. Genetic ablation of
Apaf1 dampens mitochondria which, depending on the genetic
background, make cells more or less sensitive to DNA-inducing
agents such as etoposide which, in sensitive cells, probably induces
necroptosis when the canonical apoptosis components are not
available. These studies, together with previous reports [6,9,11],
illustrate not only the complex role that Apaf1 might play in cells,
but also the importance of unravelling the network of signalling
pathways that converges in the key proteins controlling apoptosis
in probably not only cell death, but also in cell homeostasis.
Through direct binding or accessory proteins, the results indicate a
role for Apaf1 in the structural (and functional) arrangement of
homeostatic mitochondria. It would be interesting to perform a
thorough identification of the molecular mechanism as to how
Apaf1 affects the mitochondria given their relevance and central
position in cell fate decisions.
Supporting Information
Figure S1 ABT737 treatment induces cell death in
SV40IM WT MEFS but not SV40IM KO MEFS and SIM
MEFS. (A) Percentage of cell survival measured by the trypan
blue exclusion assay in SV40IM and SIM MEFS, WT and Apaf1
depleted, in the presence or absence of ABT737 (20 mM) for 24 h.
(B) Caspase-3 like activity was measured under the same
conditions described above. (C) Cells with Cyt c released measured
by the flow cytometry analysis after incubation with ABT737
(20 mM) for 24 h. In all cases, bars represent the mean of three
experiments 6 s.d.
(TIF)
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